378 related articles for article (PubMed ID: 17591302)
21. [Artificial blood - coming soon or never reaching clinical maturity?].
Schöler M; Frietsch T; Jambor C; Knels R
Dtsch Med Wochenschr; 2010 Mar; 135(12):575-81. PubMed ID: 20234994
[TBL] [Abstract][Full Text] [Related]
22. Civilian uses of hemoglobin-based oxygen carriers.
Greenburg AG; Kim HW
Artif Organs; 2004 Sep; 28(9):795-9. PubMed ID: 15320942
[TBL] [Abstract][Full Text] [Related]
23. Clinical update: Hemopure(r) - a room temperature stable hemoglobin oxygen carrier.
Jacobs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S121-2. PubMed ID: 11753717
[No Abstract] [Full Text] [Related]
24. Expectations and implications of blood sparing with hemoglobin based oxygen carriers.
Estep TN
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):93-105. PubMed ID: 17364474
[TBL] [Abstract][Full Text] [Related]
25. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial.
Kipnis K; King NM; Nelson RM
Am J Bioeth; 2006; 6(3):18-21. PubMed ID: 16754441
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin-Based Oxygen Carriers: Where Are We Now in 2023?
Chen L; Yang Z; Liu H
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837597
[TBL] [Abstract][Full Text] [Related]
27. Perfluorinated blood substitutes and artificial oxygen carriers.
Lowe KC
Blood Rev; 1999 Sep; 13(3):171-84. PubMed ID: 10527269
[TBL] [Abstract][Full Text] [Related]
28. Artificial oxygen carriers: scientific and biotechnological points of view.
Simoni J
Artif Organs; 2009 Feb; 33(2):92-6. PubMed ID: 19178451
[No Abstract] [Full Text] [Related]
29. US Navy experience with research on, and development of, hemoglobin-based oxygen carriers.
Auker CR; McCarron RM
J Trauma; 2011 May; 70(5 Suppl):S40-1. PubMed ID: 21841570
[No Abstract] [Full Text] [Related]
30. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
Kim HW; Greenburg AG
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
[TBL] [Abstract][Full Text] [Related]
31. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
32. Blood relatives: artificial oxygen carriers between promise and concern.
Shekhar C
Chem Biol; 2007 Oct; 14(10):1091-2. PubMed ID: 17961819
[No Abstract] [Full Text] [Related]
33. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back.
Yu M; Dai M; Liu Q; Xiu R
Cancer Treat Rev; 2007 Dec; 33(8):757-61. PubMed ID: 17936507
[TBL] [Abstract][Full Text] [Related]
34. Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials.
Weiskopf RB
Anesth Analg; 2010 Mar; 110(3):659-62. PubMed ID: 20185643
[No Abstract] [Full Text] [Related]
35. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
36. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
Moore EE; Moore FA; Fabian TC; Bernard AC; Fulda GJ; Hoyt DB; Duane TM; Weireter LJ; Gomez GA; Cipolle MD; Rodman GH; Malangoni MA; Hides GA; Omert LA; Gould SA;
J Am Coll Surg; 2009 Jan; 208(1):1-13. PubMed ID: 19228496
[TBL] [Abstract][Full Text] [Related]
37. Clinical contextualization and the assessment of adverse events in HBOC trials.
Greenburg AG; Pitman A; Pearce B; Kim HW
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):477-86. PubMed ID: 19039687
[TBL] [Abstract][Full Text] [Related]
38. Oxygen therapeutics in trauma and surgery.
Cohn SM
J Trauma; 2003 May; 54(5 Suppl):S193-8. PubMed ID: 12768124
[TBL] [Abstract][Full Text] [Related]
39. Artificial oxygen carriers: renewed commercial interest and scientific/technological advances.
Simoni J
Artif Organs; 2012 Feb; 36(2):123-6. PubMed ID: 22339722
[No Abstract] [Full Text] [Related]
40. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
Taguchi K; Maruyama T; Otagiri M
Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
